0001104659-22-033453.txt : 20220314
0001104659-22-033453.hdr.sgml : 20220314
20220314183211
ACCESSION NUMBER: 0001104659-22-033453
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220310
FILED AS OF DATE: 20220314
DATE AS OF CHANGE: 20220314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Miller Steven Clive
CENTRAL INDEX KEY: 0001883325
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40825
FILM NUMBER: 22738128
MAIL ADDRESS:
STREET 1: C/O WARBY PARKER INC.
STREET 2: 233 SPRING STREET, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Warby Parker Inc.
CENTRAL INDEX KEY: 0001504776
STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851]
IRS NUMBER: 800423634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 233 SPRING STREET
STREET 2: 6TH FLOOR EAST
CITY: NEW YORK
STATE: NY
ZIP: 10013
BUSINESS PHONE: (646) 847-7215
MAIL ADDRESS:
STREET 1: 233 SPRING STREET
STREET 2: 6TH FLOOR EAST
CITY: NEW YORK
STATE: NY
ZIP: 10013
FORMER COMPANY:
FORMER CONFORMED NAME: JAND, Inc.
DATE OF NAME CHANGE: 20101102
4
1
tm229170-3_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-03-10
0
0001504776
Warby Parker Inc.
WRBY
0001883325
Miller Steven Clive
C/O WARBY PARKER INC.,
233 SPRING STREET, 6TH FLOOR EAST
NEW YORK
NY
10013
0
1
0
0
Chief Financial Officer
Class A Common Stock
2022-03-10
4
M
0
13463
0
A
170907
D
Class A Common Stock
2022-03-10
4
S
0
5767
25.00
D
165140
D
Class A Common Stock
2022-03-11
4
S
0
6949
24.4335
D
158191
D
Class A Common Stock
2022-03-11
4
S
0
747
25.0455
D
157444
D
Restricted Stock Units
2022-03-10
4
M
0
1981
0
D
Class A Common Stock
1981
23112
D
Restricted Stock Units
2022-03-10
4
M
0
1326
0
D
Class A Common Stock
1326
0
D
Restricted Stock Units
2022-03-10
4
M
0
2525
0
D
Class A Common Stock
2525
19358
D
Restricted Stock Units
2022-03-10
4
M
0
2535
0
D
Class A Common Stock
2535
9294
D
Restricted Stock Units
2022-03-10
4
M
0
5096
0
D
Class A Common Stock
5096
69643
D
This filing relates to the occurrence of a RSU vesting event.
Sale of shares to cover taxes due on restricted stock units that vested, as mandated by the Issuer's equity compensation plan.
The sales reported were effected pursuant to a 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.96 to $24.90. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.99 to $25.15. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Each Restricted Stock Unit represents a contingent right to receive one share of the Company's Class A Common Stock.
The restricted stock units will vest in 48 monthly installments beginning on January 1, 2021 and will expire on January 27, 2028.
The restricted stock units will vest in 48 monthly installments beginning on January 1, 2018 and will expire on October 16, 2025.
The restricted stock units will vest in 48 monthly installments beginning on January 1, 2020 and will expire on November 19, 2026.
The restricted stock units will vest in 48 monthly installments beginning on January 1, 2019 and will expire on March 28, 2026.
The restricted stock units will vest in 48 monthly installments beginning on July 1, 2021 and will expire on June 14, 2031.
/s/ Hyung Bak, Attorney-in-Fact
2022-03-14